At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Accelerated partial breast irradiation +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ACCELERATED PARTIAL BREAST IRRADIATION USING NON-INVASIVE IMAGE-GUIDED BREAST BRACHYTHERAPY (ACCUBOOST) FOR EARLY STAGE BREAST CANCERS: A TOXICITY ASSESSMENT
In Brief
A clinical study evaluating Accelerated partial breast irradiation and Extended Follow up for Breast Cancer. Completed, enrolled 40 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsThe Miriam Hospital, Rhode Island Hospital
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedNov 2011
Primary CompletionSep 2013
Study CompletionApr 2021
TodayJul 2026
First PostedNov 1, 2011
Enrollment StartAug 1, 2011
Primary CompletionSep 12, 2013
Study CompletionApr 6, 2021
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.7 years ago
Interventions
Accelerated partial breast irradiationradiation
Accuboost APBI 34.0 Gy in 10 fractions
Extended Follow upother
This arm extends follow up at the Rhode Island Hospital location to 5 years. Annual mammograms and additional documentation is required to be submitted only if completed.